View Financial HealthGetinge 배당 및 자사주 매입배당 기준 점검 4/6Getinge 수익으로 충분히 충당되는 현재 수익률 2.5% 보유한 배당금 지급 회사입니다.핵심 정보2.5%배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률3.1%배당 성장률10.2%다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향55%최근 배당 및 자사주 매입 업데이트공시 • Apr 22+ 1 more updateGetinge AB (publ) Approves Dividend, Payable from April 28, 2026Getinge AB (publ) approved the Dividend payment at its Annual General Meeting held on April 21, 2026. In accordance with the proposal by the Board of Directors and the CEO, the AGM resolved to declare a dividend of SEK 4.75 per share. April 23, 2026 was determined as record date for dividend. The dividend is expected to be distributed by Euroclear Sweden AB starting April 28, 2026.Declared Dividend • Feb 24Dividend of kr4.75 announcedShareholders will receive a dividend of kr4.75. Ex-date: 22nd April 2026 Payment date: 28th April 2026 Dividend yield will be 25%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is covered by both earnings (57% earnings payout ratio) and cash flows (49% cash payout ratio). The dividend has increased by an average of 5.4% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 47% over the next 3 years, which should provide support to the dividend and adequate earnings cover.공시 • Jan 27Getinge AB (Publ) Proposes DividendGetinge AB (publ) announced the proposal of dividend per share of SEK 4.75 (4.60).공시 • Apr 23+ 1 more updateGetinge AB (publ) Approves Dividend, Payable on April 29, 2025Getinge AB (publ) at its AGM held on April 22, 2025 approved dividend of SEK 4.60 per share. April 24, 2025 was determined as record date for dividend. The dividend is expected to be distributed by Euroclear Sweden AB starting Tuesday April 29, 2025.모든 업데이트 보기Recent updatesValuation Update With 7 Day Price Move • May 22Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €18.75, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 19x in the Medical Equipment industry in Italy. Total returns to shareholders of 8.3% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €32.79 per share.New Risk • May 15New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.2% average weekly change).공시 • Apr 22+ 1 more updateGetinge AB (publ) Approves Dividend, Payable from April 28, 2026Getinge AB (publ) approved the Dividend payment at its Annual General Meeting held on April 21, 2026. In accordance with the proposal by the Board of Directors and the CEO, the AGM resolved to declare a dividend of SEK 4.75 per share. April 23, 2026 was determined as record date for dividend. The dividend is expected to be distributed by Euroclear Sweden AB starting April 28, 2026.공시 • Apr 10Getinge AB (publ) (OM:GETI B) acquired Pennamed Limited.Getinge AB (publ) (OM:GETI B) acquired Pennamed Limited on April 8, 2026. The acquisition strengthens Getinge’s offering to endoscopy units across the United Kingdom (UK) by combining Pennamed’s established consumables portfolio and strong customer relationships with Getinge’s expertise in endoscope reprocessing, infection control, and washer-disinfector technology. Getinge and Pennamed has combined 350 employees. Abi Godfrey, Alex Parry and Matt Harvey of Grant Thornton UK LLP acted as accountants for Pennamed Limited. Emma Orriss and Nigel Beckwith of Gosschalks LLP acted as legal advisors for Pennamed Limited. Covington & Burling Llp acted as legal advisor and Ernst & Young AB acted as accountant for Getinge AB. Getinge AB (publ) (OM:GETI B) completed the acquisition of Pennamed Limited on April 8, 2026.공시 • Mar 26+ 3 more updatesGetinge AB (publ) to Report Q2, 2026 Results on Jul 17, 2026Getinge AB (publ) announced that they will report Q2, 2026 results on Jul 17, 2026공시 • Mar 12Getinge AB (publ) Announces Malin Persson Declines Re-Election as Board Member, Effective April 21, 2026Getinge AB (publ) at its Annual General Meeting to be held on April 21, 2026, announced Malin Persson has declined re-election as board member.Declared Dividend • Feb 24Dividend of kr4.75 announcedShareholders will receive a dividend of kr4.75. Ex-date: 22nd April 2026 Payment date: 28th April 2026 Dividend yield will be 25%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is covered by both earnings (57% earnings payout ratio) and cash flows (49% cash payout ratio). The dividend has increased by an average of 5.4% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 47% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Board Change • Feb 24Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 7 highly experienced directors. Director Ulrika Dellby was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.공시 • Jan 28Getinge AB (publ), Annual General Meeting, Apr 21, 2026Getinge AB (publ), Annual General Meeting, Apr 21, 2026.공시 • Jan 27Getinge AB (Publ) Proposes DividendGetinge AB (publ) announced the proposal of dividend per share of SEK 4.75 (4.60).공시 • Dec 19Getinge AB Announces Malin Persson Declines Re-Election to the BoardGetinge AB announced that Malin Persson, a board member since 2014, has announced that she will not be available for re-election to the board in 2026.Board Change • Dec 11Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 7 highly experienced directors. Director Ulrika Dellby was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Nov 19Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 7 highly experienced directors. Director Ulrika Dellby was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.공시 • Oct 21Getinge AB (Publ) Reaffirms Earnings Guidance for the Year 2025Getinge AB (publ) reaffirmed earnings guidance for the year 2025. The company remain with expectation for organic net sales growth to be in the range of 2% to 5% and long-term financial target of over 12% EPS growth is also intact despite the headwind from tariffs and currency.Reported Earnings • Jul 21Second quarter 2025 earnings released: EPS: kr1.92 (vs kr1.88 in 2Q 2024)Second quarter 2025 results: EPS: kr1.92 (up from kr1.88 in 2Q 2024). Revenue: kr8.24b (flat on 2Q 2024). Net income: kr524.0m (up 2.1% from 2Q 2024). Profit margin: 6.4% (up from 6.2% in 2Q 2024). Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Medical Equipment industry in Italy.공시 • Jul 02Getinge AB (publ)(OM:GETI B) dropped from OMX Stockholm 30 IndexGetinge AB (publ) has been dropped from the OMX OMX Stockholm 30 Index공시 • Apr 23+ 1 more updateGetinge AB (publ) Approves Dividend, Payable on April 29, 2025Getinge AB (publ) at its AGM held on April 22, 2025 approved dividend of SEK 4.60 per share. April 24, 2025 was determined as record date for dividend. The dividend is expected to be distributed by Euroclear Sweden AB starting Tuesday April 29, 2025.공시 • Mar 28+ 1 more updateGetinge AB (publ) to Report Q3, 2025 Results on Oct 21, 2025Getinge AB (publ) announced that they will report Q3, 2025 results on Oct 21, 2025공시 • Mar 18Getinge Introduces Neural Pressure Support for the Servo-U Ventilator SystemGetinge announces the launch of its latest innovation in ICU ventilation – Neural Pressure Support (NPS) – available for both invasive and non-invasive ventilation. Building on its most personalized ventilation modes, NAVA and NIV NAVA, these two new NPS modes offer clinicians more options to provide personalized ventilation that aims to protect both the lungs and diaphragm. For years, Getinge has been market-driving when it comes to developing first-of-its-kind intensive care ventilation modes. The medtech company is introducing NPS and NIV NPS to widen its neurally controlled ventilation offering. The new Neural Pressure Support modes give clinicians the opportunity to deliver classical pressure support ventilation, enhanced with neural trigger and breath termination in synchrony with diaphragmatic muscle activity. This may be particularly beneficial for complex and challenging ICU patient groups, such as obstructive COPD patients requiring instant synchronization and fast pressurization, and restrictive ARDS patients with stiff lungs and an excessive respiratory drive.공시 • Jan 29Getinge AB (publ), Annual General Meeting, Apr 22, 2025Getinge AB (publ), Annual General Meeting, Apr 22, 2025. Location: halmstad Sweden공시 • Dec 10Getinge AB (publ) to Report Q1, 2025 Results on Apr 22, 2025Getinge AB (publ) announced that they will report Q1, 2025 results on Apr 22, 2025지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 1GETI 의 배당금 지급은 지난 10 년 동안 휘발성이었습니다.배당금 증가: 1GETI 의 배당금 지급은 지난 10 년 동안 증가했습니다.배당 수익률 vs 시장Getinge 배당 수익률 vs 시장1GETI의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (1GETI)2.5%시장 하위 25% (IT)1.6%시장 상위 25% (IT)4.7%업계 평균 (Medical Equipment)2.3%분석가 예측 (1GETI) (최대 3년)3.1%주목할만한 배당금: 1GETI 의 배당금( 2.5% )은 Italian 시장에서 배당금 지급자의 하위 25%( 1.57% )보다 높습니다.고배당: 1GETI 의 배당금( 2.5% )은 Italian 시장에서 배당금 지급자의 상위 25%( 4.67% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: 합리적인 지급 비율 ( 54.8% )을 통해 1GETI 의 배당금 지급은 수익으로 충당됩니다.주주 현금 배당현금 흐름 범위: 합리적으로 낮은 현금 지급 비율 ( 39% )로 1GETI 의 배당금 지급은 현금 흐름으로 잘 충당됩니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YIT 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/29 18:56종가2026/05/29 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Getinge AB (publ)는 24명의 분석가가 다루고 있습니다. 이 중 10명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관null nullABG Sundal CollierScott BardoBerenbergDelphine Le LouetBernstein21명의 분석가 더 보기
공시 • Apr 22+ 1 more updateGetinge AB (publ) Approves Dividend, Payable from April 28, 2026Getinge AB (publ) approved the Dividend payment at its Annual General Meeting held on April 21, 2026. In accordance with the proposal by the Board of Directors and the CEO, the AGM resolved to declare a dividend of SEK 4.75 per share. April 23, 2026 was determined as record date for dividend. The dividend is expected to be distributed by Euroclear Sweden AB starting April 28, 2026.
Declared Dividend • Feb 24Dividend of kr4.75 announcedShareholders will receive a dividend of kr4.75. Ex-date: 22nd April 2026 Payment date: 28th April 2026 Dividend yield will be 25%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is covered by both earnings (57% earnings payout ratio) and cash flows (49% cash payout ratio). The dividend has increased by an average of 5.4% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 47% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
공시 • Jan 27Getinge AB (Publ) Proposes DividendGetinge AB (publ) announced the proposal of dividend per share of SEK 4.75 (4.60).
공시 • Apr 23+ 1 more updateGetinge AB (publ) Approves Dividend, Payable on April 29, 2025Getinge AB (publ) at its AGM held on April 22, 2025 approved dividend of SEK 4.60 per share. April 24, 2025 was determined as record date for dividend. The dividend is expected to be distributed by Euroclear Sweden AB starting Tuesday April 29, 2025.
Valuation Update With 7 Day Price Move • May 22Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €18.75, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 19x in the Medical Equipment industry in Italy. Total returns to shareholders of 8.3% over the past year. Simply Wall St's valuation model estimates the intrinsic value at €32.79 per share.
New Risk • May 15New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Italian stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (7.2% average weekly change).
공시 • Apr 22+ 1 more updateGetinge AB (publ) Approves Dividend, Payable from April 28, 2026Getinge AB (publ) approved the Dividend payment at its Annual General Meeting held on April 21, 2026. In accordance with the proposal by the Board of Directors and the CEO, the AGM resolved to declare a dividend of SEK 4.75 per share. April 23, 2026 was determined as record date for dividend. The dividend is expected to be distributed by Euroclear Sweden AB starting April 28, 2026.
공시 • Apr 10Getinge AB (publ) (OM:GETI B) acquired Pennamed Limited.Getinge AB (publ) (OM:GETI B) acquired Pennamed Limited on April 8, 2026. The acquisition strengthens Getinge’s offering to endoscopy units across the United Kingdom (UK) by combining Pennamed’s established consumables portfolio and strong customer relationships with Getinge’s expertise in endoscope reprocessing, infection control, and washer-disinfector technology. Getinge and Pennamed has combined 350 employees. Abi Godfrey, Alex Parry and Matt Harvey of Grant Thornton UK LLP acted as accountants for Pennamed Limited. Emma Orriss and Nigel Beckwith of Gosschalks LLP acted as legal advisors for Pennamed Limited. Covington & Burling Llp acted as legal advisor and Ernst & Young AB acted as accountant for Getinge AB. Getinge AB (publ) (OM:GETI B) completed the acquisition of Pennamed Limited on April 8, 2026.
공시 • Mar 26+ 3 more updatesGetinge AB (publ) to Report Q2, 2026 Results on Jul 17, 2026Getinge AB (publ) announced that they will report Q2, 2026 results on Jul 17, 2026
공시 • Mar 12Getinge AB (publ) Announces Malin Persson Declines Re-Election as Board Member, Effective April 21, 2026Getinge AB (publ) at its Annual General Meeting to be held on April 21, 2026, announced Malin Persson has declined re-election as board member.
Declared Dividend • Feb 24Dividend of kr4.75 announcedShareholders will receive a dividend of kr4.75. Ex-date: 22nd April 2026 Payment date: 28th April 2026 Dividend yield will be 25%, which is higher than the industry average of 1.7%. Sustainability & Growth Dividend is covered by both earnings (57% earnings payout ratio) and cash flows (49% cash payout ratio). The dividend has increased by an average of 5.4% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 47% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Board Change • Feb 24Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 7 highly experienced directors. Director Ulrika Dellby was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
공시 • Jan 28Getinge AB (publ), Annual General Meeting, Apr 21, 2026Getinge AB (publ), Annual General Meeting, Apr 21, 2026.
공시 • Jan 27Getinge AB (Publ) Proposes DividendGetinge AB (publ) announced the proposal of dividend per share of SEK 4.75 (4.60).
공시 • Dec 19Getinge AB Announces Malin Persson Declines Re-Election to the BoardGetinge AB announced that Malin Persson, a board member since 2014, has announced that she will not be available for re-election to the board in 2026.
Board Change • Dec 11Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 7 highly experienced directors. Director Ulrika Dellby was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Nov 19Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 7 highly experienced directors. Director Ulrika Dellby was the last director to join the board, commencing their role in 2025. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
공시 • Oct 21Getinge AB (Publ) Reaffirms Earnings Guidance for the Year 2025Getinge AB (publ) reaffirmed earnings guidance for the year 2025. The company remain with expectation for organic net sales growth to be in the range of 2% to 5% and long-term financial target of over 12% EPS growth is also intact despite the headwind from tariffs and currency.
Reported Earnings • Jul 21Second quarter 2025 earnings released: EPS: kr1.92 (vs kr1.88 in 2Q 2024)Second quarter 2025 results: EPS: kr1.92 (up from kr1.88 in 2Q 2024). Revenue: kr8.24b (flat on 2Q 2024). Net income: kr524.0m (up 2.1% from 2Q 2024). Profit margin: 6.4% (up from 6.2% in 2Q 2024). Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Medical Equipment industry in Italy.
공시 • Jul 02Getinge AB (publ)(OM:GETI B) dropped from OMX Stockholm 30 IndexGetinge AB (publ) has been dropped from the OMX OMX Stockholm 30 Index
공시 • Apr 23+ 1 more updateGetinge AB (publ) Approves Dividend, Payable on April 29, 2025Getinge AB (publ) at its AGM held on April 22, 2025 approved dividend of SEK 4.60 per share. April 24, 2025 was determined as record date for dividend. The dividend is expected to be distributed by Euroclear Sweden AB starting Tuesday April 29, 2025.
공시 • Mar 28+ 1 more updateGetinge AB (publ) to Report Q3, 2025 Results on Oct 21, 2025Getinge AB (publ) announced that they will report Q3, 2025 results on Oct 21, 2025
공시 • Mar 18Getinge Introduces Neural Pressure Support for the Servo-U Ventilator SystemGetinge announces the launch of its latest innovation in ICU ventilation – Neural Pressure Support (NPS) – available for both invasive and non-invasive ventilation. Building on its most personalized ventilation modes, NAVA and NIV NAVA, these two new NPS modes offer clinicians more options to provide personalized ventilation that aims to protect both the lungs and diaphragm. For years, Getinge has been market-driving when it comes to developing first-of-its-kind intensive care ventilation modes. The medtech company is introducing NPS and NIV NPS to widen its neurally controlled ventilation offering. The new Neural Pressure Support modes give clinicians the opportunity to deliver classical pressure support ventilation, enhanced with neural trigger and breath termination in synchrony with diaphragmatic muscle activity. This may be particularly beneficial for complex and challenging ICU patient groups, such as obstructive COPD patients requiring instant synchronization and fast pressurization, and restrictive ARDS patients with stiff lungs and an excessive respiratory drive.
공시 • Jan 29Getinge AB (publ), Annual General Meeting, Apr 22, 2025Getinge AB (publ), Annual General Meeting, Apr 22, 2025. Location: halmstad Sweden
공시 • Dec 10Getinge AB (publ) to Report Q1, 2025 Results on Apr 22, 2025Getinge AB (publ) announced that they will report Q1, 2025 results on Apr 22, 2025